268
Participants
Start Date
September 15, 2022
Primary Completion Date
July 31, 2025
Study Completion Date
August 31, 2025
Efzofitimod 3 mg/kg
EfzofitimodIV infusion every 4 weeks for a total of 12 doses
Efzofitimod 5 mg/kg
EfzofitimodIV infusion every 4 weeks for a total of 12 doses
Placebo
Placebo IV infusion every 4 weeks for a total of 12 doses
aTyr Investigative Site, Middletown
aTyr Investigative Site, Albany
aTyr Investigative Site, Philadelphia
aTyr Investigative Site, Washington D.C.
aTyr Investigative Site, Milan
aTyr Investigative Site, Baltimore
aTyr Investigative Site, Falls Church
aTyr Investigative Site, Richmond
aTyr Investigative Site, Durham
aTyr Investigative Site, Greenville
aTyr Investigative Site, Madrid
aTyr Investigative Site, Madrid
aTyr Investigative Site, Atlanta
aTyr Investigative Site, Hanover
aTyr Investigative Site, Toulouse
aTyr Investigative Site, Gainesville
aTyr Investigative Site, Weston
aTyr Investigative Site, Tampa
aTyr Investigative Site, Trieste
aTyr Investigative Site, Montpellier
aTyr Investigative Site, Padua
aTyr Investigative Site, Birmingham
aTyr Investigative Site, Dickson
aTyr Investigative Site, La Tronche
aTyr Investigative Site, Santander
aTyr Investigative Site, Jackson
aTyr Investigative Site, Louisville
aTyr Investigative Site, Cleveland
aTyr Investigative Site, Essen
aTyr Investigative Site, Cincinnati
aTyr Investigative Site, Valencia
aTyr Investigative Site, Forlì
aTyr Investigative Site, Detroit
aTyr Investigative Site, Ada
aTyr Investigative Site, Florence
aTyr Investigative Site, Siena
aTyr Investigative Site, Minneapolis
aTyr Investigative Site, Rochester
aTyr Investigative Site, Chicago
aTyr Investigative Site, Chicago
aTyr Investigative Site, St Louis
aTyr Investigative Site, Heidelberg
aTyr Investigative Site, New Orleans
aTyr Investigative Site, Oklahoma City
aTyr Investigative Site, Paris
aTyr Investigative Site, Dallas
aTyr Investigative Site, Dallas
aTyr Investigative Site, Houston
aTyr Investigative Site, Freiburg im Breisgau
aTyr Investigative Site, Napoli
aTyr Investigative Site, Denver
aTyr Investigative Site, Salt Lake City
aTyr Investigative Site, Phoenix
aTyr Investigative Site, Los Angeles
aTyr Investigative Site, Bobigny
aTyr Investigative Site, Catania
aTyr Investigative Site, Sacramento
aTyr Investigative Site, Portland
aTyr Investigative Site, Boston
aTyr Investigative Site, Charleston
aTyr Investigative Site, Salvador
aTyr Investigative Site, Porto Alegre
aTyr Investigative Site, São Bernardo do Campo
aTyr Investigative Site, São Paulo
aTyr Investigative Site, São Paulo
aTyr Investigative Site, Rome
Kyorin Investigative Site, Aomori
Kyorin Investigative Site, Fukuoka
Kyorin Investigative Site, Fukushima
Kyorin Investigative Site, Hokkaido
Kyorin Investigative Site, Hokkaido
Kyorin Investigative Site, Hyōgo
Kyorin Investigative Site, Kanagawa
Kyorin Investigative Site, Kanagawa
aTyr Investigative Site, Kumamoto
Kyorin Investigative Site, Miyagi
Kyorin Investigative Site, Okayama
Kyorin Investigative Site, Osaka
Kyorin Investigative Site, Shimane
Kyorin Investigative Site, Shizuoka
Kyorin Investigative Site, Tokyo
Kyorin Investigative Site, Tokyo
aTyr Investigative Site, Nieuwegein
aTyr Investigative Site, Barcelona
aTyr Investigative Site, Barcelona
aTyr Investigative Site, Birmingham
aTyr Investigative Site, Cambridge
aTyr Investigative Site, Cottingham
aTyr Investigative Site, Coventry
aTyr Investigative Site, London
aTyr Investigative Site, London
Collaborators (1)
Kyorin Pharmaceutical Co.,Ltd
INDUSTRY
aTyr Pharma, Inc.
INDUSTRY